Beyond the Pages: CCJM Podcast
Beyond the Pages: CCJM Podcast provides an in-depth look at articles from the Cleveland Clinic Journal of Medicine. Through moderated interviews with the authors and expert article reviews, clinicians gain a better understanding of clinical breakthroughs that are changing medical practice. The show focuses on how these advances can be practically applied in patient care.
Episodes
AI in Medicine PART TWO
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education
AI in Medicine PART ONE
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education
Complement inhibition PART TWO
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune
Complement inhibition PART ONE
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune
Update on antiobesity medications in adults PART TWO
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications c
Update on antiobesity medications in adults PART ONE
In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications c
Lipoprotein(a) in clinical practice
Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).
Testing for PFAS ‘forever chemicals’ PART TWO
This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”
Testing for PFAS ‘forever chemicals’ PART ONE
This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”
Single-pill combination antihypertensive therapy
This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”
Hypercholesterolemia not responding to statins
This podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Dr. Faaiq N. Aslam, Mayo Clinic, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “My adult patient’s hypercholesterolemia is not responding to statins—what’s next?”
Recreational cannabis legalization
This podcast features discussion with Dr. Akhil Anand and Dr. Hannah Snyder, and moderated by Dr. Craig Nielsen, all of Cleveland Clinic. Together, they explore the Cleveland Clinic Journal of Medicine article, “Recreational cannabis legalization: Potential implications for individual and community health.” The conversation delves into the multifaceted issues surrounding recreational cannabis lega
Psychedelic assisted therapy PART TWO
In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and
Psychedelic assisted therapy PART ONE
In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and
Diabetes technology PART TWO
In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach t
Diabetes technology PART ONE
In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach t
Unprovoked Venous Thromboembolism
Listen as Neeladri Misra, MD, Sutter Roseville Medical Center, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss a one-minute consult article that answers the question “Should every patient with an unprovoked venous thromboembolism have a hypercoagulable workup?”
Vaccine hesitancy in the time of COVID, PART TWO
In a two-part podcast, listen as Dr. H. Clifford Lane, National Institute of Allergy and Infectious Diseases, and Dr. Steven M. Gordon, Cleveland Clinic, join moderator Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, to discuss vaccine hesitancy in the time of COVID. Topics discussed include the historical context of vaccine hesitancy, current knowledge and gaps regardi
Vaccine hesitancy in the time of COVID, PART ONE
Listen as Dr. H. Clifford Lane, National Institute of Allergy and Infectious Diseases, and Dr. Steven M. Gordon, Cleveland Clinic, join moderator Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, to discuss the historical context of vaccine hesitancy, current knowledge and gaps regarding COVID-19 vaccines, and how to effectively guide patients in making informed decisions
Glucocorticoid-induced Adrenal Insufficiency and Glucocorticoid withdrawal Syndrome: Part Two
In a two-part podcast, listen as Drs. M. Cecilia Lansang and Dingfeng Li, Cleveland Clinic, and Dr. Noura Nachawi, University of Michigan, join moderator Dr. Craig Nielsen, Cleveland Clinic, to diseases of the adrenal glands, focusing on both glucocorticoid-induced adrenal insufficiency (GIAI) and glucocorticoid withdrawal syndrome.
Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome PART ONE
In a two-part podcast, listen as Drs. M. Cecilia Lansang and Dingfeng Li, Cleveland Clinic, and Dr. Noura Nachawi, University of Michigan, join moderator Dr. Craig Nielsen, Cleveland Clinic, to diseases of the adrenal glands, focusing on both glucocorticoid-induced adrenal insufficiency (GIAI) and glucocorticoid withdrawal syndrome.
Gastroparesis for the non-gastroenterologist
Listen as Drs. Jorge Araujo-Duran, Arjun Chatterjee, and Samita Garg, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss gastroparesis, a heterogeneous motility disorder characterized by nausea, vomiting, and postprandial fullness. The authors discuss their article that explores challenges nongastroenterologists may encounter and how they can use current recommendati
AI in clinical practice: ChatGPT PART TWO
In this two-part podcast, Dr. Anthony Bozzo, McGill University, and Fred Jiawen Deng, University of Toronto, join moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the newest AI-powered platforms, such as ChatGPT (Chat Generative Pre-trained Transformer). Listen as they aim to demystify the role of ChatGPT and similar technologies in clinical settings, highlighting their limitations and cu
AI in clinical practice: ChatGPT PART ONE
In this two-part podcast, Dr. Anthony Bozzo, McGill University, and Fred Jiawen Deng, University of Toronto, join moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the newest AI-powered platforms, such as ChatGPT (Chat Generative Pre-trained Transformer). Listen as they aim to demystify the role of ChatGPT and similar technologies in clinical settings, highlighting their limitations and cu
Management of benign prostatic hyperplasia PART TWO
In this two-part podcast, Drs. Ayodeji E. Sotimehin and Bradley C. Gill, Cleveland Clinic, join moderator Dr. Adam Brown, Cleveland Clinic, to discuss guideline-backed surgical and procedural interventions for benign prostatic hyperplasia. Listen as they explore how to choose the most suitable intervention for patients based on factors such as prostate characteristics, patient preference, and the
Management of benign prostatic hyperplasia PART ONE
In this two-part podcast, Drs. Ayodeji E. Sotimehin and Bradley C. Gill, Cleveland Clinic, join moderator Dr. Adam Brown, Cleveland Clinic, to discuss guideline-backed surgical and procedural interventions for benign prostatic hyperplasia. Listen as they explore how to choose the most suitable intervention for patients based on factors such as prostate characteristics, patient preference, and the
Treatments for obstructive sleep apnea PART TWO
In this two-part podcast, Drs. Loutfi S. Aboussouan and Alan Kominsky, Cleveland Clinic, sit down with moderator Dr. Adam Brown, Cleveland Clinic, to discuss treatment options for obstructive sleep apnea, including identifying reasons for poor adherence to positive airway pressure treatment, discussing alternatives, and managing patient expectations.
Treatments for obstructive sleep apnea PART ONE
In this two-part podcast, Drs. Loutfi S. Aboussouan and Alan Kominsky, Cleveland Clinic, sit down with moderator Dr. Adam Brown, Cleveland Clinic, to discuss treatment options for obstructive sleep apnea, including identifying reasons for poor adherence to positive airway pressure treatment, discussing alternatives, and managing patient expectations.
Metformin Therapy for Weight Loss in Patient Without Diabetes-Part Two
In this two-part podcast, Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).
Metformin Therapy for Weight Loss in Patient Without Diabetes-Part One
Dr. Paloma Rodriguez, Cleveland Clinic, sits down with Dr. Andrei Brateanau, Senior Associate Program Director of the Internal Medicine Residency Program in Cleveland Clinic’s Medicine Institute, to discuss evidence that supports the weight-loss effects of metformin in adults with obesity and without type 2 diabetes (T2D).
Getting to the Root of the Problem
Dr. Steven Gordon, Chairman of Cleveland Clinic’s Department of Infectious Diseases, discusses with Dr. Brian Mandell, Editor-in-Chief of Cleveland Clinic Journal of Medicine, if patients should receive antibiotics to prevent infective endocarditis before dental procedures.
A New Policy Update on Breastfeeding
Dr. Heidi Szugye, Cleveland Clinic’s Breastfeeding Medicine Medical Director, and Dr. Suet Kam Lam, Cleveland Clinic’s Breastfeeding Medicine Assistant Medical Director, discuss the most recent policy statement on breastfeeding from the AAP and the impact on clinical guidance.
Surgical De-Escalation: Benign High-Risk, Breast Lesions Part Two
In a two part podcast, Dr. Benjamin Calhoun, Lineberger Comprehensive Cancer Center of University of North Carolina at Chapel Hill, and Dr. Holly Pederson, Cleveland Clinic, discuss evidence-based criteria needed for selecting patients for non-operative management of the benign high-risk, breast lesions and the potential challenges in implementing observation in all patient populations.
Surgical De-Escalation: Benign High-Risk, Breast Lesions Part One
In a two part podcast, Dr. Benjamin Calhoun, Lineberger Comprehensive Cancer Center of University of North Carolina at Chapel Hill, and Dr. Holly Pederson, Cleveland Clinic, discuss evidence-based criteria needed for selecting patients for non-operative management of the benign high-risk, breast lesions and the potential challenges in implementing observation in all patient populations.
Autoimmunity and POTS: Implications in Diagnosis and Management
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
Recommended
megahired.com
Telli Talks with Telli Swift
Harmonize Your Life: Conversation on Self-Care for Women of Color
Lighting the Legal Career Path
High Performance Mindset | Learn from World-Class Leaders, Consultants, Athletes & Coaches about Mindset
Pintastic® Pinterest Podcast
Learn 50 English Phrases While You Sleep | Everyday English Phrases & Vocabulary
The Daily
The Joe Rogan Experience
World News Tonight with David Muir
Talk About Talk - Executive & Leadership Communication Skills
This Past Weekend w/ Theo Von
